Elena Ramos Varas
Early detection of ovarian cancer is expected to dramatically improve patient survival but is hampered by a lack of effective screening biomarkers. By identifying RNA biomarkers in liquid biopsies, we aim to provide a potential solution to this situation. Our experience in molecular Biology techniques together and in Bioinformatics will help us to work towards this goal. Liquid biopsies are becoming an increasingly attractive resource of cancer biomarkers. Biofluids that are closer to the primary tumor, and still easy to obtain in a routine setting, may be enriched for tumor-derived nucleic acids and thus allow increased detection sensitivity. Demonstrating the relevance of these biopsies in the identification of cancer biomarkers might serve as an example for other types of cancer.
I obtained a Master of Science in Biotechnology in 2020, at the University of Cordoba (Spain). With the advances of next generation sequencing technologies and Bioinformatics, I decided to follow the Master of Science in Bioinformatics at the UGent (2020). This led me to my first employment as an associate bioinformatic scientist.
Currently, I am full-time doctoral researcher at UGent willing to apply my knowledge on both bioinformatics and the wet-lab for cancer research.